Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions

Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

Dr. Agarwal’s crosses Rs. 2,000 crore revenue milestone in FY26

Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26

Sun Pharma reports FY26 revenue of Rs. 58,220 crore, net profit at Rs. 11,479 crore

Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth

Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure

Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum